A new saliva test could provide a quick and cheap way to screen for breast cancer
As you plan healthcare coverage for March, Ochsner Health has experts on standby to cover several topics. Are younger people getting colorectal cancer?: Colorectal cancer has always been a cause for concern among middle-aged and older men and women. However,…
In JVSTB, researchers report successful results from a hand-held breast cancer screening device that can detect breast cancer biomarkers from a tiny sample of saliva.
Three leading Florida academic cancer centers – Sylvester Comprehensive Cancer Center at the University of Miami Health System, Moffitt Cancer Center and the University of Florida Health Cancer Center – have joined to fund thousands of dollars for four projects statewide to help people detect and treat cancer early.
Today, Memorial Sloan Kettering Cancer Center (MSK), in collaboration with Miami-based creative agency Alma, launched a bilingual public service campaign to promote the importance of routine cancer screenings.
Findings indicate the importance of earlier and more frequent prostate cancer screening for Black men.
A new study by researchers at the American Cancer Society shows that adults in the United States with prior insurance coverage disruptions are significantly less likely to receive guideline-concordant and past-year cancer screening, compared to people with continuous coverage.
A new study found that an alternative model to identify patients with lung cancer eligible for screening was more accurate than the currently used method based on the United States Preventive Services Task Force (USPSTF) criteria.
A majority of older adults disagree with the idea of using life expectancy as part of guidelines that say which patients should get cancer screenings such as mammograms and colonoscopies, a new poll finds.
The American Cancer Society estimates about 115,000 women will be diagnosed with a gynecologic cancer this year. That’s one case about every five minutes. These types of malignancies originate in the female reproductive organs, most commonly the cervix, endometrium or ovaries. This…
Knowing every abnormality in your body is tempting, but experts say ignorance may be bliss
AI can predict certain forms of esophageal and stomach cancer Michigan Medicine study says.
Americans have gotten at least 12 million more years of life to live because of preventive cancer screenings they’ve gotten the past 25 years, a new study estimates. That adds up to at least $6.5 trillion in added economic impact, because of scans and tests that look for early signs of breast, colon, cervical and lung cancer in adults at the highest risk.
A study of more than 50,000 women found that continued breast cancer screening after age 70 was associated with a greater incidence of cancer that likely would not have caused symptoms in the patient’s lifetime. These findings suggest that overdiagnosis may be common among older women who are diagnosed with breast cancer after screening. The study is published in Annals of Internal Medicine.
Many types of preventive care have been available for years with no cost to the patient. But that provision now hangs in the balance, because of a court case. Two professors explain what’s at stake and why.
As part of a continued focus on making cancer screenings more accessible to the greater Philadelphia community, Penn Medicine is providing free cancer screenings, no insurance required, including advanced 3D mammograms, in West Philadelphia this June.
Delays in cancer screening during the COVID-19 pandemic will likely cause a significant increase in cancer cases that could have been caught earlier with screening, and may now be diagnosed at later stages, according to a new research article published in the Journal of the American College of Surgeons.
The U.S. Preventive Services Task Force (USPSTF) has updated mammography screening guidelines for breast cancer detection to every other year beginning at age 40 instead of 50. This recommendation is based on new evidence of a rise in breast cancer…
Researchers at the UNC Gillings School of Global Public Health and UNC Lineberger Comprehensive Cancer Center found mailing human papillomavirus (HPV) self-collection tests and offering assistance to book in-clinic screening appointments to under-screened, low-income women improved cervical cancer screening nearly two-fold compared to scheduling assistance alone.
Five years ago, the World Health Organization (WHO) announced a global call to eliminate cervical cancer. Because nearly all cervical cancers are caused by an initial infection with oncogenic types of human papillomavirus (HPV), screening for the virus is critical to preventing and treating the disease.However, providing HPV screening only within clinical settings may limit access to screening for many under-served women across the United States and here, in North Carolina.
Repeated mammograms contain data on changes in breast density over time that could help identify women at high risk of breast cancer and even reveal which breast is likely to be affected, according to a study by researchers at Washington University School of Medicine in St. Louis.
New American College of Radiology® (ACR®) breast cancer screening guidelines now call for all women — particularly Black and Ashkenazi Jewish women — to have risk assessment by age 25 to determine if screening earlier than age 40 is needed.
Researchers at Washington University School of Medicine in St. Louis have identified four important signs and symptoms that signal an elevated risk of early-onset colorectal cancer. The incidence of colorectal cancer is rising in people under 50, making it important to recognize such signs.
Although genetic mutations in BRCA1 or BRCA2 are associated with a younger onset of breast and ovarian cancer, women with these genetic mutations continue to face a high risk of cancer incidence after age 50, even if they have not been previously diagnosed with cancer.
According to a new, nationwide study led by researchers at the American Cancer Society, millions of people in the United States continued to miss critical cancer screening tests during the second year of the COVID-19 pandemic.
Colorectal cancer is one of the most treatable cancers, especially if it is detected early; however, many people do not undergo recommended screening, even despite the availability of at-home stool fecal immunochemical test (FIT) kits.
A comprehensive analysis of more than 100,000 colorectal cancer (CRC) cases, led by researchers at the Fred Hutchinson Cancer Center in Seattle and 200 scientific collaborators worldwide, has identified more than 100 new genetic risk factors strongly linked with the disease.
Analysis showed that in 2019 more than 1.3 million women received cervical cancer screening-associated services, such as a Pap test, colposcopy and other cervical procedures, after age 65. While these services cost more than $83 million, the researchers concluded they were of “unclear clinical appropriateness.”
Researchers from The RNA Institute at the University at Albany have been awarded $1.4 million to investigate stress-induced RNA modifications and associated cell response. The focus of the study — “wobble uridines” in tRNA — could hold important clues for treating bacterial infections and detecting cancer.
Commercially available noninvasive screening tests for colorectal cancer—a fecal immunochemical test (FIT) and the multi-target stool DNAtest—are equally effective for screening patients with early-stage colorectal cancer.
Colorectal cancer patients with certain clinical characteristics may benefit from more frequent chest imaging to help identify and target cancer that has spread to the lungs.
Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine’s Game Changer vehicles, which bring health education and free screenings for many cancer types to South Florida communities in need, are for the first time offering prostate-specific antigen (PSA) screening for prostate cancer.
Rates of most types of cancer are higher in men than in women for reasons that are unclear.
A new large study led by researchers at the American Cancer Society shows older age and smoking are the two most important risk factors associated with a relative and absolute five-year risk of developing any cancer. The findings also demonstrate that in addition to age and smoking history, clinicians should consider excess body fatness, family history of any cancer, and several other factors that may help patients determine if they may benefit from enhanced cancer screening or prevention interventions. The data was published today in the journal Cancer.
The National Comprehensive Cancer Network (NCCN) has published new NCCN Guidelines for Patients: Breast Cancer Screening and Diagnosis to help people understand their personal risk for breast cancer, when they should begin screening, and how often to screen—in order to detect cancer earlier, for more treatment options and better outcomes.
A study that surveyed cancer screening data included in medical journals worldwide from January 2020 into December 2021 showed significant decreases in the number of screenings for breast, colorectal and cervical cancers during the early phase of the Covid-19 pandemic.
UC San Diego researchers have created a mathematical model to help predict risk of anal cancer in persons with HIV infection and aid patients and doctors regarding screening decisions.
Multi-Cancer Early Detection Health Equity Demonstration Three-Year Program Aims to Improve Cancer Outcomes Among Underserved Populations and Develop Best Practices for Deployment of Innovative Technologies in Community Settings
African American men are at the highest risk for both developing and dying from prostate cancer. It is essential that this population take preventative measures and seek appropriate treatment if diagnosed.
Communication between patients and their primary care providers is key to ensuring effective cancer care, both before diagnosis and after treatment, according to two recent papers led by University of Michigan Rogel Cancer Center researchers.
The College of American Pathologists (CAP) Foundation announced in July 2021 a new fundraising campaign with a minimum goal of $2 million that will secure life-saving cancer screening and pathology education and training programs for the next decade.
On Saturday, August 14, 2021, qualified women who make an appointment can receive free cervical and breast cancer screenings as part of Loyola Medicine’s 6th annual See, Test and Treat® event. See, Test and Treat® will be held at the Loyola Outpatient Center, 2160 S. First Ave., Maywood, Illinois. Interested women are invited to call 708-216-7284 to verify eligibility and make an appointment.
Selected Recipients of the New “Back to Screening Award for Research Advocacy Excellence” will be Honored at Fight Colorectal Cancer’s “Path to a Cure” Event in December 2021.
The COVID-19 pandemic knocked many women off schedule for important health appointments, a new study finds, and many didn’t get back on schedule even after clinics reopened. The effect may have been greatest in areas where such care is already likely falling behind experts’ recommendations.
Adolescents and young adults living in rural versus metropolitan U.S. counties and those living farther from the hospital where they were diagnosed are more likely to be detected at a later cancer stage, when it is generally less treatable and have lower survival rates compared with those living in metropolitan counties and closer to the reporting hospital, finds a new study from the Brown School at Washington University in St. Louis.
During the COVID-19 pandemic, Johns Hopkins Medicine Media Relations is focused on disseminating current, accurate and useful information to the public via the media. As part of that effort, we are distributing our “COVID-19 Tip Sheet: Story Ideas from Johns Hopkins” every other Wednesday.
The study, led by Tengfei Luo, a professor in the Department of Aerospace and Mechanical Engineering at the University of Notre Dame, will be initiated by astronauts aboard the International Space Station (ISS).
Today, the United States Preventive Services Task Force (USPSTF) finalized its recommendation to adapt the colorectal cancer (CRC) screening guidelines and lower the age to begin screening to 45 instead of 50. “Shifting current age-specific screening rates to five years…
Now more than ever, we are reminded that health and wellness should always be a top priority. National Women’s Health Month and Mother’s Day, both celebrated in May, are important reminders that women can take control of their health by making feasible lifestyle choices and focusing on preventive care to lower the risk of certain cancers.
Nearly 10 million cancer screenings in the U.S. failed to happen because of the COVID-19 pandemic, according to a study published in JAMA Oncology, a publication of the American Medical Association.